ADAPY stock
Adaptimmune Therapeutics plc (ADAPY) short interest & short volume · 1.2M shares short
Adaptimmune Therapeutics plc official short interest (FINRA, twice monthly) and daily short volume (FINRA Reg SHO), with history, % of float and days to cover.
What changed
ADAPY short interest was little changed at 1.2M shares in the Oct 15, 2026 report (5.0 days to cover).
Short interest
Official, twice monthly · settled Oct 15, 2026
- Shares short
- 1.2M
- prior 1.2M
- % of float
- —
- no float on file
- Days to cover
- 5.0
- avg vol 244K
- Change vs prior report
- 0.0%
| Report date | Shares short | $ value short | Change | % float | Days to cover | Price |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | 1.2M | $40K | 0.0% | — | 5.0 | $0.03 |
| Sep 30, 2026 | 1.2M | $46K | -0.2% | — | 2.1 | $0.04 |
| Sep 15, 2026 | 1.2M | $30K | 0.0% | — | 4.6 | $0.03 |
| Aug 31, 2026 | 1.2M | $28K | 0.0% | — | 4.1 | $0.02 |
| Aug 14, 2026 | 1.2M | $35K | 0.0% | — | 5.5 | $0.03 |
| Jul 31, 2026 | 1.2M | $39K | 0.0% | — | 1.7 | $0.03 |
Days to cover is short interest divided by FINRA's average daily volume for the period: how many average days of trading it would take shorts to buy back.
Source: FINRA equity short interest (twice monthly) · Settlement Oct 15, 2026
Daily short volume
Share of each day's volume sold short · FINRA Reg SHO
No FINRA daily short volume on file for ADAPY yet.
Short squeeze score (model)
Model, not a forecast: 40 pts short interest % of float (full at 30%), 25 pts days to cover (full at 10), 15 pts rise in short interest since the prior report (full at +50%), 20 pts price gain since the settlement date (full at +25%). Missing inputs score 0.
ADAPY's squeeze score and its inputs with Lician Pro.Start 3-day trial — $149/yr
Market-wide: most shorted stocks, biggest changes and unusual short volume · ADAPY overview
ADAPY short interest FAQ
What is ADAPY's short interest?
Adaptimmune Therapeutics plc (ADAPY) had 1.2M shares sold short and not yet covered in FINRA's Oct 15, 2026 settlement report.
How many days to cover does ADAPY have?
5.0 days: 1.2M shares short divided by an average daily volume of 244K for the Oct 15, 2026 period.
Is ADAPY short interest rising or falling?
ADAPY short interest was little changed (0.0%) from 1.2M to 1.2M shares in the Oct 15, 2026 report.
Is ADAPY a short squeeze candidate?
Lician's squeeze watch scores ADAPY 13 out of 100 (low) from the Oct 15, 2026 report: days to cover 12.5/25, change in short interest vs prior report 0/15. It is a transparent model of how crowded the short side is, not a forecast that a squeeze will happen.
Where is ADAPY listed?
Adaptimmune Therapeutics plc (ADAPY) common stock is listed on PINK.
What is ADAPY's latest revenue?
Latest cached Adaptimmune Therapeutics plc (ADAPY) revenue for Dec 31, 2024 was $178.0M.
Where is ADAPY short volume listed?
Cached FINRA short volume for Adaptimmune Therapeutics plc (ADAPY) is listed at https://lician.com/short-interest/adapy.
Not investment advice. Figures as filed or reported, not a live feed.